Gene · 3113
Papers2,625
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,625
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing. | BMC Bioinformatics | 2023 | 37380943 | PubTator, text mining | PubMed |
| Detection of Nonsynonymous Single Variants in Human HLA-DRB1 Exon 2 Associated with Renal Transplant Rejection. | Medicina (Kaunas) | 2023 | 37374320 | PubTator, text mining | PubMed |
| Differences in the Tumor Microenvironment of EBV-Associated Gastric Cancers Revealed Using Single-Cell Transcriptome Analysis. | Cancers (Basel) | 2023 | 37370788 | PubTator, text mining | PubMed |
| Characterization of the novel HLA-DPA1*02:03:05 allele by next generation sequencing. | HLA | 2023 | 37370240 | PubTator, text mining | PubMed |
| Development and validation of dynamic bioenergetic model for intermittent ergometer cycling. | Eur J Appl Physiol | 2023 | 37369795 | PubTator, text mining | PubMed |
| Identification and Validation of Hub Immune-Related Genes in Non-Alcoholic Fatty Liver Disease. | Int J Gen Med | 2023 | 37362825 | PubTator, text mining | PubMed |
| SDR16C5 promotes proliferation and migration and inhibits apoptosis in pancreatic cancer. | Open Life Sci | 2023 | 37360782 | PubTator, text mining | PubMed |
| Exploring Prognostic Biomarkers of Acute Myeloid Leukemia to Determine Its Most Effective Drugs from the FDA-Approved List through Molecular Docking and Dynamic Simulation. | Biomed Res Int | 2023 | 37359050 | PubTator, text mining | PubMed |
| Identification of a novel HLA-DPA1 allele, HLA-DPA1*02:102Q. | HLA | 2023 | 37354083 | PubTator, text mining | PubMed |
| Blood- and Urine-Based Liquid Biopsy for Early-Stage Cancer Investigation: Taken Clear Renal Cell Carcinoma as a Model. | Mol Cell Proteomics | 2023 | 37348606 | PubTator, text mining | PubMed |
| Integrative single-cell multiomics analyses dissect molecular signatures of intratumoral heterogeneities and differentiation states of human gastric cancer. | Natl Sci Rev | 2023 | 37347037 | PubTator, text mining | PubMed |
| Peripheral blood cellular dynamics of rheumatoid arthritis treatment informs about efficacy of response to disease modifying drugs. | Sci Rep | 2023 | 37344505 | PubTator, text mining | PubMed |
| The current advances of lncRNAs in breast cancer immunobiology research. | Front Immunol | 2023 | 37342324 | PubTator, text mining | PubMed |
| PPARG: A Promising Therapeutic Target in Breast Cancer and Regulation by Natural Drugs. | PPAR Res | 2023 | 37334066 | PubTator, text mining | PubMed |
| A unique expression pattern of LAG3 distinct from that of other immune checkpoints in diffuse large B-cell lymphoma. | Cancer Med | 2023 | 37326144 | PubTator, text mining | PubMed |
| Novel HLA allele associations with susceptibility, staging, symptomatic state, autoimmune hepatitis and hepatocellular carcinoma events for primary biliary cholangitis in the Japanese population. | Front Immunol | 2023 | 37325616 | PubTator, text mining | PubMed |
| Discovery of three novel HLA-DPA1 alleles, HLA-DPA1*01:147N, 01:03:47, and 02:106 using next-generation sequencing. | HLA | 2023 | 37315941 | PubTator, text mining | PubMed |
| Common Genetic Variants of Response to Hepatitis B Vaccines Correlate with Risks of Chronic Infection of Hepatitis B Virus: A Community-Based Case-Control Study. | Int J Mol Sci | 2023 | 37298692 | PubTator, text mining | PubMed |
| Targeting KRASG12V mutations with HLA class II-restricted TCR for the immunotherapy in solid tumors. | Front Immunol | 2023 | 37287989 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomics reveal changes in cell heterogeneity during progression of human tendinopathy. | BMC Biol | 2023 | 37280595 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/papers?page=19